Clinical trials
Phase 3 Cellulitis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 5 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
| Terminated | 2 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Durata Therapeutics Inc., an affiliate of Allergan plc | 3 |
| Melinta Therapeutics, Inc. | 3 |
| Pfizer | 3 |
| Arpida AG | 2 |
| Forest Laboratories | 2 |
| GlaxoSmithKline | 2 |
| Paratek Pharmaceuticals Inc | 2 |
| Verrica Pharmaceuticals Inc. | 2 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 2 |
| 59th Medical Wing | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cellulitis | 34 |
| Abscess | 12 |
| Wound Infection | 8 |
| Bacterial Infections | 7 |
| Infections | 6 |
| Skin Diseases, Bacterial | 5 |
| Soft Tissue Infections | 5 |
| Surgical Wound Infection | 5 |
| Skin Diseases | 4 |
| Skin Diseases, Infectious | 3 |
Trials
Showing 76 to 34 of 34. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.